To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with relevant stakeholders on the supply of Liraglutide to the NHS.
We are aware of global supply issues with glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), which are licensed for treating patients with type 2 diabetes. This includes liraglutide. We have issued guidance in the form of a Medicine Supply Notificat...
Liraglutide